Commentary Open Access
Volume 4 | Issue 2 | DOI: https://doi.org/10.33696/cancerimmunol.4.066

Clutch Control: Changing the Speed and Direction of CAR-T Cell Therapy

  • 1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
  • 2Department of Medicine, Harvard Medical School, Boston, MA 02115, USA
  • 3Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA
  • 4Current Address: Dynamic Cell Therapies, Inc., 127 Western Ave., Allston, MA 02134, USA
  • 5Department of Surgery, Brigham and Women’s Hospital, Boston, MA 02115, USA
  • 6Department of Surgery, Harvard Medical School, Boston, MA 02115, USA
  • #These authors contributed equally
+ Affiliations - Affiliations

Corresponding Author

Carl D. Novina, carl_novina@dfci.harvard.edu

Received Date: September 07, 2022

Accepted Date: October 21, 2022

Author Information X